Maternal serum second trimester AFP and hCG in pregnancies with placenta previa

Prenatal Diagnosis

Volumn 20, Issue 2, 2000, Pages 100-102

  Heikkilä, Annaleena ^b   Heinonen, Seppo ^a   Kirkinen, Pertti ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Down's syndrome; Placenta previa; Serum screening

Indexed keywords

ALPHA FETOPROTEIN; BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; FINLAND; HORMONE BLOOD LEVEL; HUMAN; MATERNAL AGE; MATERNAL SERUM; PLACENTA PREVIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN; COHORT STUDIES; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA PREVIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 0033983497     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(200002)20:2<100::AID-PD767>3.0.CO;2-5     Document Type: Article

References (14)

1. Blundell G, Ashby JP, Martin C, Shearing CH, Langdale-Brown B, Keeling J, Ellis PM, Shade M, Chambers SE, Wenham PR. 1999. Clinical follow-up of high mid-trimester maternal intact human chorionic gonadotrophin concentrations in singleton pregnancies. Prenat Diagn 19: 219-223.
2. Cuckle HS, Wald NJ, Thompson S. 1987. Estimating a woman's risk of having a pregnancy associated with Down syndrome using her age and serum alpha-fetoprotein level. Brit J Obstet Gynaecol 94: 387-402.
3. Esterman A, Finlay TH, Dancis J. 1996. The effect of hypoxia on term trophoblast: hormone synthesis and release. Placenta 17: 217-222.
4. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. 1997. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
5. Gravett CP, Buckmaster JG, Watson PT, Gravett MG. 1992. Elevated second trimester maternal serum β-hCG concentrations and subsequent adverse pregnancy outcome. Am J Med Gen 44: 485-486.
6. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA. 1993. An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 168: 1852-1857.
7. Penttilä IM, Ryynänen M, Hämäläinen E, Puhakainen E, Savolainen K. 1993. Quality specifications for S-AFP and S-hCG-â determinations for screening of fetal abnormalities. Upsala J Med Sci 98: 375-380.
8. Ribbert LS, Kornman LH, De Wolf BT, Simons AH, Jansen CA, Beekhuis JR, Mantingh A. 1996. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 16: 35-38.
9. Räty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. 1999. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 19: 122-127.
10. Strohmer H, Kiss H, Mosl B, Egarter C, Husslein P, Knofler M. 1997. Hypoxia downregulates continuous and interleukin-1-induced expression of human chorionic gonadotropin in chorioncarcinoma cells. Placenta 18: 597-604.
11. Tan SL, Doyle P, Campbell S, Beral V. Rizk B, Brindsen P, Mason B, Edwards RG. 1992. Obstetric outcome of in vitro fertilization pregnancies compared with normally conceived pregnancies. Am J Obstet Gynecol 167: 778-784.
12. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. 1988. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.
13. Wenström KD, Owen J, Boots LR, DuBard MB. 1994. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol 171: 1038-1041.
14. Zelop C, Nadel A, Frigoletto FD, Pauker S, MacMillan M, Benacerraf BR. 1992. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 80: 693-694.